Viewing nowCombinationPimaten Tablet 30/2.5 mg
Fimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Ajou Pharmaceuticals Co., Ltd.

MFDS item code 202300082 · Approved 2023.01.06
Treatment of essential hypertension not adequately controlled with fimasartan monotherapy
Used to effectively lower blood pressure in patients with essential hypertension whose blood pressure is not adequately controlled by monotherapy with pimasartan potassium.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time every day (e.g., in the morning). It is recommended that the dose be adjusted using fimasartan before administering this medicine. However, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. ㆍ 30/2.5 mg: Administer to patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 60/2.5 mg: Administer to patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. ㆍ 60/5 mg: Administer to patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy or this medicine 60/2.5 mg. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Elderly patients No initial dose adjustment is necessary for elderly patients 70 years of age or younger. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with 30 mg of fimasartan in this medicine. Patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.
The safety and efficacy of this medicine have not been established in children and adolescents 18 years of age or younger.
This medication may cause serious harm to the fetus and newborn when taken during pregnancy, especially in the second and third trimesters; therefore, it should be discontinued immediately upon confirmation of pregnancy. It should not be taken by individuals allergic to the active ingredient or similar components. Women who are pregnant or breastfeeding, patients undergoing kidney dialysis, patients with severe liver impairment, and those with certain conditions such as biliary obstruction should not use this medication. Particular caution is needed when using this medication in patients with low blood volume or decreased sodium, impaired kidney function, renal artery hypertension, severe hypotension, the elderly, etc. Rarely, side effects may include dizziness, headaches, facial swelling, urinary disturbances, insomnia, and flushing. Blood pressure may drop too low; therefore, careful monitoring is necessary when starting or increasing the dosage. Periodic monitoring of serum potassium levels is advisable while taking this medication. Consultation with a doctor or pharmacist is required when taken with other antihypertensive agents, diuretics, potassium-sparing diuretics, some antibiotics, and anti-inflammatory medications due to potential interactions. Use during pregnancy or breastfeeding is not recommended; if necessary, consult a specialist. Safety has not been established for children and adolescents under 18 years of age. In case of overdose, severe hypotension or cardiac issues may occur, so the dosage must be strictly adhered to, and if unusual symptoms arise, immediate medical attention is necessary. This medication should be kept out of reach of children and should not be transferred to other containers.
Dizziness, orthostatic dizziness, headache, facial edema, peripheral edema, urinary disturbance, insomnia, flushing, syncope, sedation, migraine, dyspepsia, vomiting, nausea, upper abdominal pain, asthenia, foreign body sensation, increased liver enzyme levels, decreased platelet count, increased serum creatine phosphokinase levels, cough, muscle contraction, musculoskeletal rigidity, pruritus, localized urticaria, facial flushing, erectile dysfunction, epilepsy, amyotrophic lateral sclerosis, neuropathy, neuronitis, facial paralysis, normal pressure hydrocephalus, spinal stenosis, acute pancreatitis, intestinal obstruction, hemorrhagic duodenal ulcer, appendicitis, hemorrhoids, abdominal pain, intracranial hemorrhage, transient ischemic attack, atherosclerosis, worsened cerebral infarction, cerebral hemorrhage, liver cancer, colorectal carcinoma, neoplasm of unspecified nature, cervical cancer, prostate cancer, acute renal failure, chronic renal failure, kidney stones, pyelonephritis, urinary incontinence, rhinitis, fibrosing alveolitis, pharyngitis, pneumonia, pulmonary disease, death, aggravated lower back pain, osteoarthritis, arthralgia, hypoglycemia, hyperkalemia, pulmonary embolism, purpura, bradycardia, atrial fibrillation, coronary artery disease, aortic stenosis, heart failure, increased blood pressure, acute hepatitis, benign pituitary neoplasm, otitis media, uterine prolapse, recurrent cancer, cerebral infarction, fracture, chest pain, carpal tunnel syndrome, pulmonary tuberculosis, axillary pain, periorbital edema, allergy, chills, nasal polyps, edema, fatigue, fever, neck/shoulder pain, muscle weakness, tendinitis, osteomyelitis, shoulder girdle syndrome, lateral epicondylitis, synovitis, sciatica, jaw pain, arthralgia, osteoporosis, myalgia, pharyngitis, upper respiratory infection, sputum, rhinitis, epistaxis, bronchitis, sensory abnormalities, numbness, tremors, hypertonia, insomnia, depression, anxiety, memory impairment, loss of appetite, gastroesophageal reflux, gastritis, diarrhea, constipation, functional gastrointestinal disorder, gastroenteritis, frequent urination, urinary incontinence, dysuria, hyperlipidemia, dyslipidemia, hypoglycemia, tinnitus, hearing impairment, hearing loss, pelvic inflammatory disease, vaginitis, benign prostatic hyperplasia, scrotal pain, blood pressure fluctuations, fatty liver, localized inflammation, soft tissue inflammation, lymphadenopathy, postoperative pain, headache, drowsiness, fatigue, edema, palpitations, weakness, malaise, pain, weight gain/loss, hypotension, vasculitis, hypertonicity, sensory loss, sensory abnormalities, peripheral neuropathy, taste disturbance, tremor, extrapyramidal disorder, changes in bowel habit, dry mouth, gingival hypertrophy, pancreatitis, hyperglycemia, hair loss, hyperhidrosis, purpura, skin discoloration, urticaria, toxic epidermal necrolysis, increased urinary frequency, nocturia, hepatitis, jaundice, elevated liver enzyme levels, pruritus, vascular edema, erythema multiforme, myocardial infarction, arrhythmia, chest pain, hypotension, sinoatrial block, atrioventricular block, abdominal discomfort, epigastric pain, diarrhea, loose stools, erythematous rash, maculopapular rash, malaise, heat sensation, impaired glucose tolerance, weakness
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a container that does not allow light to enter. Additionally, the medication is best kept at room temperature between 1 degree and 30 degrees Celsius, avoiding extremely hot or cold locations.
White, round-edged square film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Ajou Pharmaceuticals Co., Ltd.
CombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 7.48mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
NBK Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Kips Biopharma Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Bionex Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Aprogen BioLogic Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.